miRNA	microRNA
EMT	epithelial-to-mesenchymal transition
ER	Estrogen receptor
PR	Progesteron receptor
HER2	Human epidermal growth factor receptor 2
ISH	in situ hybrizidation
BC	breast cancer
TNBC	triple negative breast cancer
E2F1	E2F Transcription Factor 1
LAMC1	Laminin Subunit Gamma 1
KLF12	Krüppel-like factor 12
NFIB	Nuclear factor I/B
PDX	Patient-derived xenograft
AMOT	Angiomotin
ERp29	endoplasmic reticulum protein 29
CLCN3	chloride voltage-gated channel 3
ZEB1	E-box binding homeobox 1
SIP1	Smad interacting protein 1
Ubc13	Ubiquitin-conjugating enzyme E2 13
5-AZA	5-Aza-2′-deoxycytidine
TSA	trichostatin A
HMGB3	high mobility group box 3
RAGE	receptor for advanced glycation end products
TG2	transglutaminase 2
BCSC	breast cancer stem cell
RunX2	RUNX Family Transcription Factor 2
ITGA5	Integrin α5
EGFR	Epidermal Growth Factor Receptor
VEGF-A	vascular endothelial growth factor A
FGF2	fibroblast growth factor 2
LncRNA	long-non-coding RNA
CAF	cancer associated fibroblast
NF	normal fibroblast
MVs	microvesicles
MSC	mesenchymal stromal cell
HMGB1	high mobility group box 1
WT	Wild Type
MEC	mammary epithelial cells